Cardiac safety of the adjuvant Trastuzumab in a Moroccan population: observational monocentric study of about 100 patients

Table 2 Characteristics of the LVEF decrease in patients with cardiotoxicity (n = 38)

Cardiotoxicity criteria	No. patients	% Patients with cardiotoxicity	% of patient total
LVEF decrease <50%	7	18,42	7
LVEF decrease >10 points below baseline	16	42,10	16
LVEF decrease > 15 points below baseline	22	57,89	22

ISSN: 1756-0500